Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
9 pending office actions • 9 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
The Royal Institution For The Advancement Of Learning / Mcgill University has 3 pending office actions within the Chemistry & Materials technology area. These matters are spread across 3 distinct examiners and distinct art units. This distribution suggests that the institution's research and subsequent patent filings in chemistry are diverse enough to trigger reviews from multiple specialized units within the patent office. Such a spread requires a coordinated but flexible prosecution strategy to address the varying priorities of different art units.
The busiest examiner, DU, SURBHI M, is responsible for 1 busiest examiner pending action. Given the division of labor among multiple examiners, the institution faces a decentralized prosecution environment where each case requires a unique approach tailored to different personnel. There is no overlap in the personnel currently reviewing these active applications, meaning that an allowance or a successful argument in one case is unlikely to provide direct leverage in the others. Practitioners must manage these distinct tracks independently to ensure the best outcomes for the institution's chemistry-related intellectual property.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (22%) |
| §103 only | 2 (22%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 4 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DWIVEDI, MAHESH H | 1 | 69.7% | +4.4% |
| VALLE, ERNESTO | 1 | 65.8% | +32.9% |
| SIRCAR, ALISHA JITENDRA | 1 | 54.8% | +51.6% |
| MENZ, DOUGLAS M | 1 | 88.6% | +4.8% |
| JEONG, YOUNGSUL | 1 | 71.6% | +21.7% |
| GROOMS, TIFFANY NICOLE | 1 | 57.8% | +46.3% |
| SULLIVAN, DENNIS JOHN | 1 | 57.6% | +48.0% |
| OGUNTADE, ELIZABETH BISOLA | 1 | 50.0% | +100.0% |
| ABU ALI, SHUANGYI | 1 | 45.4% | +37.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18550708 | SUBSTRATE FOR SEMICONDUCTOR DEVICE, SEMICONDUCTOR COMPONENT AND METHOD OF MANUFACTURING SAME | MENZ, DOUGLAS M | 43d overdue |
| 17730337 | AUTOMATED FLUIDIC ASSAY BASED ON MOLECULARLY IMPRINTED POLYMER FOR DETECTION OF ANTIBODIES AND PROTEINS IN BODY FLUIDS | OGUNTADE, ELIZABETH BISOLA | 16d |
| 18294356 | METHODS AND SYSTEMS FOR SELECTING ACTIONS FROM A SET OF ACTIONS TO BE PERFORMED IN AN ENVIRONMENT AFFECTED BY DELAYS | DWIVEDI, MAHESH H | — |
| 18573562 | PHOSPHODIESTERASE INHIBITORS FOR THE MITIGATION OF FRAGILE X SYNDROME SYMPTOMS | VALLE, ERNESTO | — |
| 18283647 | ASSESSMENT OF CARDIOVASCULAR FUNCTION THROUGH CONCOMITANT ACQUISITION OF ECG AND BIA | SIRCAR, ALISHA JITENDRA | — |
| 17581320 | LOW PRESSURE CARBONATION CURING OF CONCRETE ELEMENTS AND PRODUCTS IN AN EXPANDABLE ENCLOSURE | ABU ALI, SHUANGYI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17730337 | AUTOMATED FLUIDIC ASSAY BASED ON MOLECULARLY IMPRINTED POLYMER FOR DETECTION OF ANTIBODIES AND PROTEINS IN BODY FLUIDS | OGUNTADE, ELIZABETH BISOLA | 16d |
| 18573562 | PHOSPHODIESTERASE INHIBITORS FOR THE MITIGATION OF FRAGILE X SYNDROME SYMPTOMS | VALLE, ERNESTO | — |
| 18283647 | ASSESSMENT OF CARDIOVASCULAR FUNCTION THROUGH CONCOMITANT ACQUISITION OF ECG AND BIA | SIRCAR, ALISHA JITENDRA | — |
| 18264668 | FIBER-BASED MATERIALS FOR WATER TREATMENT | JEONG, YOUNGSUL | — |
| 18344507 | OLIGONUCLEOTIDES CONTAINING 2'-DEOXY-2'FLUORO-BETA-D-ARABINOSE NUCLEIC ACID (2'-FANA) FOR TREATMENT AND DIAGNOSIS OF RETROVIRAL DISEASES | GROOMS, TIFFANY NICOLE | — |
| 18255682 | THERAPEUTIC APPLICATIONS OF TYPE 1 INSULIN-LIKE GROWTH FACTOR (IGF-1) RECEPTOR ANTAGONISTS | SULLIVAN, DENNIS JOHN | — |
| 17581320 | LOW PRESSURE CARBONATION CURING OF CONCRETE ELEMENTS AND PRODUCTS IN AN EXPANDABLE ENCLOSURE | ABU ALI, SHUANGYI | — |
| Art Unit | Apps |
|---|---|
| 2168 | 1 |
| 1623 | 1 |
| 3792 | 1 |
| 2897 | 1 |
| 1772 | 1 |
| 1637 | 1 |
| 1642 | 1 |
| 1677 | 1 |
| 1731 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18294356 | METHODS AND SYSTEMS FOR SELECTING ACTIONS FROM A SET OF ACTIONS TO BE PERFORMED IN AN ENVIRONMENT AFFECTED BY DELAYS | DWIVEDI, MAHESH H | 2168 | §101§103 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18573562 | PHOSPHODIESTERASE INHIBITORS FOR THE MITIGATION OF FRAGILE X SYNDROME SYMPTOMS | VALLE, ERNESTO | 1623 | §102§103 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18283647 | ASSESSMENT OF CARDIOVASCULAR FUNCTION THROUGH CONCOMITANT ACQUISITION OF ECG AND BIA | SIRCAR, ALISHA JITENDRA | 3792 | §101§102§103§112 | Final Rejection | — | Pending | Sep 22, 2023 |
| 18550708 | SUBSTRATE FOR SEMICONDUCTOR DEVICE, SEMICONDUCTOR COMPONENT AND METHOD OF MANUFACTURING SAME | MENZ, DOUGLAS M | 2897 | §102§103 | Final Rejection | 43d overdue | Pending | Sep 15, 2023 |
| 18264668 | FIBER-BASED MATERIALS FOR WATER TREATMENT | JEONG, YOUNGSUL | 1772 | §103 | Final Rejection | — | Pending | Aug 08, 2023 |
| 18344507 | OLIGONUCLEOTIDES CONTAINING 2'-DEOXY-2'FLUORO-BETA-D-ARABINOSE NUCLEIC ACID (2'-FANA) FOR TREATMENT AND DIAGNOSIS OF RETROVIRAL DISEASES | GROOMS, TIFFANY NICOLE | 1637 | §103 | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18255682 | THERAPEUTIC APPLICATIONS OF TYPE 1 INSULIN-LIKE GROWTH FACTOR (IGF-1) RECEPTOR ANTAGONISTS | SULLIVAN, DENNIS JOHN | 1642 | §103§112DPOther | Non-Final OA | — | Pending | Jun 02, 2023 |
| 17730337 | AUTOMATED FLUIDIC ASSAY BASED ON MOLECULARLY IMPRINTED POLYMER FOR DETECTION OF ANTIBODIES AND PROTEINS IN BODY FLUIDS | OGUNTADE, ELIZABETH BISOLA | 1677 | §103§112 | Final Rejection | 16d | Pending | Apr 27, 2022 |
| 17581320 | LOW PRESSURE CARBONATION CURING OF CONCRETE ELEMENTS AND PRODUCTS IN AN EXPANDABLE ENCLOSURE | ABU ALI, SHUANGYI | 1731 | §102§103 | Final Rejection | — | Pending | Jan 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Royal Institution for the Advancement of Learning/mcgill University has 9 pending office actions as of October 2026, spread across 9 art units and 9 examiners.
Mahesh H Dwivedi has the most, with 1 of The Royal Institution for the Advancement of Learning/mcgill University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
